NCLEX vs. FDGRX

Last updated Jun 3, 2026

NCLEX (Nicholas Limited Edition Fund) and FDGRX (Fidelity Growth Company Fund) are both mutual funds - NCLEX is a Small Cap Growth Equities fund managed by Nicholas, while FDGRX is a Large Cap Growth Equities fund managed by Fidelity. Over the past 10 years, NCLEX returned 7.33%/yr vs 23.01%/yr for FDGRX. A 0.78 correlation means they provide meaningful diversification when combined. NCLEX charges 0.85%/yr vs 0.79%/yr for FDGRX.

Performance

NCLEX vs. FDGRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nicholas Limited Edition Fund (NCLEX) and Fidelity Growth Company Fund (FDGRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NCLEX achieves a -5.61% return, which is significantly lower than FDGRX's 23.69% return. Over the past 10 years, NCLEX has underperformed FDGRX with an annualized return of 7.33%, while FDGRX has yielded a comparatively higher 23.01% annualized return.

NCLEX

• 1D: 1.62%
• 1M: 1.92%
• YTD: -5.61%
• 6M: -5.60%
• 1Y: -10.19%
• 3Y*: 1.08%
• 5Y*: -0.92%
• 10Y*: 7.33%

FDGRX

• 1D: 0.75%
• 1M: 9.19%
• YTD: 23.69%
• 6M: 19.33%
• 1Y: 49.90%
• 3Y*: 31.65%
• 5Y*: 17.30%
• 10Y*: 23.01%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NCLEX vs. FDGRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NCLEX Nicholas Limited Edition Fund	-5.61%	-10.41%	11.91%	17.17%	-23.71%	19.07%	22.67%	27.36%	-0.94%	19.93%
FDGRX Fidelity Growth Company Fund	23.69%	18.54%	37.18%	47.25%	-33.86%	22.57%	67.42%	38.40%	-4.14%	36.76%

Correlation

The correlation between NCLEX and FDGRX is 0.47, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.47
Correlation (3Y) Calculated over the trailing 3-year period	0.60
Correlation (5Y) Calculated over the trailing 5-year period	0.74
Correlation (10Y) Calculated over the trailing 10-year period	0.75
Correlation (All Time) Calculated using the full available price history since May 19, 1987	0.78

Over the past year, the correlation between NCLEX and FDGRX has dropped to 0.47 - well below their long-term average of 0.78, suggesting their price drivers have been diverging.

Return for Risk

NCLEX vs. FDGRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NCLEX

NCLEX Risk / Return Rank: 1
NCLEX Sharpe Ratio Rank: 1
NCLEX Sortino Ratio Rank: 1
NCLEX Omega Ratio Rank: 1
NCLEX Calmar Ratio Rank: 1
NCLEX Martin Ratio Rank: 1

FDGRX

FDGRX Risk / Return Rank: 78
FDGRX Sharpe Ratio Rank: 87
FDGRX Sortino Ratio Rank: 67
FDGRX Omega Ratio Rank: 70
FDGRX Calmar Ratio Rank: 86
FDGRX Martin Ratio Rank: 82

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NCLEX vs. FDGRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nicholas Limited Edition Fund (NCLEX) and Fidelity Growth Company Fund (FDGRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NCLEX	FDGRX	Difference
Sharpe ratio Return per unit of total volatility	-0.64	2.81	-3.45
Sortino ratio Return per unit of downside risk	-0.81	3.42	-4.23
Omega ratio Gain probability vs. loss probability	0.91	1.47	-0.56
Calmar ratio Return relative to maximum drawdown	-0.50	4.08	-4.58
Martin ratio Return relative to average drawdown	-1.05	15.39	-16.44
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NCLEX vs. FDGRX - Sharpe Ratio Comparison

The current NCLEX Sharpe Ratio is -0.64, which is lower than the FDGRX Sharpe Ratio of 2.81. The chart below compares the historical Sharpe Ratios of NCLEX and FDGRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NCLEX	FDGRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.64	2.81	-3.45
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.05	0.73	-0.77
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.38	0.99	-0.61
Sharpe Ratio (All Time) Calculated using the full available price history	0.52	0.70	-0.18

Drawdowns

NCLEX vs. FDGRX - Drawdown Comparison

The maximum NCLEX drawdown since its inception was -48.68%, smaller than the maximum FDGRX drawdown of -71.62%. Use the drawdown chart below to compare losses from any high point for NCLEX and FDGRX.

Drawdown Indicators

	NCLEX	FDGRX	Difference
Max Drawdown Largest peak-to-trough decline	-48.68%	-71.62%	+22.94%
Max Drawdown (1Y) Largest decline over 1 year	-21.36%	-12.60%	-8.76%
Max Drawdown (3Y) Largest decline over 3 years	-28.50%	-26.19%	-2.31%
Max Drawdown (5Y) Largest decline over 5 years	-28.50%	-40.25%	+11.75%
Max Drawdown (10Y) Largest decline over 10 years	-35.79%	-40.25%	+4.46%
Current Drawdown Current decline from peak	-21.03%	0.00%	-21.03%
Average Drawdown Average peak-to-trough decline	-8.28%	-15.91%	+7.63%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.16%	3.34%	+6.82%

Volatility

NCLEX vs. FDGRX - Volatility Comparison

Nicholas Limited Edition Fund (NCLEX) has a higher volatility of 5.09% compared to Fidelity Growth Company Fund (FDGRX) at 4.40%. This indicates that NCLEX's price experiences larger fluctuations and is considered to be riskier than FDGRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NCLEX	FDGRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.09%	4.40%	+0.69%
Volatility (6M) Calculated over the trailing 6-month period	12.11%	14.43%	-2.32%
Volatility (1Y) Calculated over the trailing 1-year period	16.92%	18.47%	-1.55%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.52%	23.93%	-4.41%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.21%	23.39%	-4.18%

NCLEX vs. FDGRX - Expense Ratio Comparison

NCLEX has a 0.85% expense ratio, which is higher than FDGRX's 0.79% expense ratio.

Dividends

NCLEX vs. FDGRX - Dividend Comparison

NCLEX's dividend yield for the trailing twelve months is around 7.98%, while FDGRX has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FDGRX Fidelity Growth Company Fund	0.00%	0.00%	8.86%	3.83%	7.20%	10.67%	8.86%	3.84%	6.38%	4.73%	6.16%	3.92%
NCLEX Nicholas Limited Edition Fund	7.98%	7.53%	2.51%	2.43%	6.22%	16.44%	5.10%	5.66%	10.72%	7.97%	10.68%	8.05%

Frequently Asked Questions

Can I hold both NCLEX and FDGRX in my portfolio?

NCLEX and FDGRX have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NCLEX or FDGRX?

NCLEX has higher volatility (5.09%) compared to FDGRX (4.40%). In terms of maximum drawdown, NCLEX dropped -48.68% vs FDGRX's -71.62%.

Which has better risk-adjusted returns?

FDGRX currently has the higher Sharpe Ratio (2.81 vs -0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.